Resistance to Some New Drugs and Prevalence of ESBL- and MBL-Producing Enterobacteriaceae Uropathogens Isolated from Diabetic Patients.

Life (Basel) · 2022 · PMC9788504 · PMID 36556490

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Carbapenems are the drug of choice for the treatment of infections caused by ESBL producers, but an increasing trend of resistance against these drugs has been reported in many Asian countries, including Pakistan [ 20 ].

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.